These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38762616)

  • 1. Assessing the combined impact of fatty liver-induced TGF-β1 and LPS-activated macrophages in fibrosis through a novel 3D serial section methodology.
    Ishiyama S; Hayatsu M; Toriumi T; Tsuda H; Watanabe K; Kasai H; Kishigami S; Mochizuki K; Mikami Y
    Sci Rep; 2024 May; 14(1):11404. PubMed ID: 38762616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
    Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity.
    Yang M; Kimchi ET; Staveley-O'Carroll KF; Li G
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation.
    Nagasaki A; Sakamoto S; Chea C; Ishida E; Furusho H; Fujii M; Takata T; Miyauchi M
    Sci Rep; 2020 Mar; 10(1):4134. PubMed ID: 32139740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
    Ni XX; Li XY; Wang Q; Hua J
    J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-specific deletion of chitinase-3-like 1 protein ameliorates murine diet-induced steatohepatitis progression.
    Kim AD; Kui L; Kaufmann B; Kim SE; Leszczynska A; Feldstein AE
    J Mol Med (Berl); 2023 Jul; 101(7):813-828. PubMed ID: 37166517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis.
    Okina Y; Sato-Matsubara M; Matsubara T; Daikoku A; Longato L; Rombouts K; Thanh Thuy LT; Ichikawa H; Minamiyama Y; Kadota M; Fujii H; Enomoto M; Ikeda K; Yoshizato K; Pinzani M; Kawada N
    J Hepatol; 2020 Oct; 73(4):882-895. PubMed ID: 32330605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to cigarette smoke precipitates simple hepatosteatosis to NASH in high-fat diet fed mice by inducing oxidative stress.
    Fouda S; Khan A; Chan SMH; Mahzari A; Zhou X; Qin CX; Vlahos R; Ye JM
    Clin Sci (Lond); 2021 Sep; 135(17):2103-2119. PubMed ID: 34427662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways.
    Yong Q; Huang C; Chen B; An J; Zheng Y; Zhao L; Peng C; Liu F
    Biomed Pharmacother; 2024 Aug; 177():116952. PubMed ID: 38917754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Interplay Between Sonic Hedgehog and Transforming Growth Factor-β1 in Human Nonalcoholic Steatohepatitis.
    Zhou X; Wang P; Ma Z; Li M; Teng X; Sun L; Wan G; Li Y; Guo L; Liu H
    Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):154-160. PubMed ID: 32044884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice.
    Furusho H; Miyauchi M; Hyogo H; Inubushi T; Ao M; Ouhara K; Hisatune J; Kurihara H; Sugai M; Hayes CN; Nakahara T; Aikata H; Takahashi S; Chayama K; Takata T
    J Gastroenterol; 2013 Nov; 48(11):1259-70. PubMed ID: 23307045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
    Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
    Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
    Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target.
    Tutusaus A; de Gregorio E; Cucarull B; Cristóbal H; Aresté C; Graupera I; Coll M; Colell A; Gausdal G; Lorens JB; García de Frutos P; Morales A; Marí M
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):349-368. PubMed ID: 31689560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the macrophage-hepatic stellate cell interaction by targeting macrophage peroxisome proliferator-activated receptor gamma to prevent non-alcoholic steatohepatitis progression in mice.
    Ni XX; Ji PX; Chen YX; Li XY; Sheng L; Lian M; Guo CJ; Hua J
    Liver Int; 2022 Dec; 42(12):2696-2712. PubMed ID: 36165186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis.
    Prestigiacomo V; Weston A; Messner S; Lampart F; Suter-Dick L
    PLoS One; 2017; 12(6):e0179995. PubMed ID: 28665955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
    Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
    Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease.
    Romualdo GR; Da Silva TC; de Albuquerque Landi MF; Morais JÁ; Barbisan LF; Vinken M; Oliveira CP; Cogliati B
    Environ Toxicol; 2021 Feb; 36(2):168-176. PubMed ID: 32918399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retinoic acid receptor β2 agonist reduces hepatic stellate cell activation in nonalcoholic fatty liver disease.
    Trasino SE; Tang XH; Jessurun J; Gudas LJ
    J Mol Med (Berl); 2016 Oct; 94(10):1143-1151. PubMed ID: 27271256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.